Apollo Hospitals Gains 2.32%: 6 Key Factors Driving the Week’s Momentum

8 June: New 52-Week High and Call Option Surge Signal Bullish Momentum

Apollo Hospitals began the week strongly, hitting a new 52-week high intraday peak of Rs.8,490 on 8 June 2026. The stock closed at Rs.8,354.55, up 0.61% on the day, significantly outperforming the Sensex which declined 1.33%. This price action reflected robust sectoral strength amid a challenging market backdrop.

Derivatives activity was particularly notable, with call options at the Rs.8,500 strike expiring on 30 June seeing 7,177 contracts traded, generating a turnover of approximately Rs.1,391.7 lakhs. Open interest stood at 1,538 contracts, indicating strong bullish positioning ahead of expiry. The stock’s technicals were supportive, trading above all key moving averages and signalling sustained momentum.

However, delivery volumes declined sharply by 74.61% compared to the five-day average, suggesting a shift towards derivatives trading rather than outright equity purchases. Despite this, liquidity remained sufficient for sizeable trades, supporting active investor participation.

9 June: All-Time High and Continued Open Interest Growth

The bullish momentum extended on 9 June, with Apollo Hospitals reaching a fresh 52-week high of Rs.8,491.15. The stock closed at this peak, gaining 2.05% on the day and outperforming the hospital sector’s 1.22% gain and the Sensex’s 0.88% rise. This marked the third consecutive day of gains, accumulating a 3.04% return over this period.

Open interest surged again, rising 10.12% to 36,502 contracts, accompanied by a volume of 33,341 contracts traded. The combined futures and options value reached approximately Rs.42,634 crores, underscoring the stock’s liquidity and attractiveness in the derivatives market. Delivery volumes increased by 8.75%, signalling renewed investor confidence and longer-term holding interest.

Technical indicators remained bullish, with the stock trading above all key moving averages and maintaining strong upward momentum. Institutional ownership remained high at 65.61%, reinforcing the stock’s market stability and appeal.

10 June: New 52-Week High of Rs.8,591.1 and Sustained Uptrend

Apollo Hospitals continued its upward trajectory on 10 June, hitting a new 52-week high of Rs.8,591.1, a 0.72% gain on the day. This marked four consecutive sessions of gains, delivering a cumulative return of 4.01%. The stock outperformed the Sensex, which rose 0.55%, and the hospital sector, which gained 0.32%.

Financial fundamentals underpinning this rally remained strong, with a high ROCE of 17.13% and half-year ROCE of 17.41%. Net sales grew at an annualised rate of 19.03%, and operating profit margins stood at 38.67%. Quarterly net sales and PBDIT reached record highs of Rs.6,605.50 crore and Rs.1,011 crore respectively, reflecting operational excellence.

Valuation metrics remained attractive, with an enterprise value to capital employed ratio of 8.1 and a PEG ratio of 1.7. The stock’s market capitalisation rose to Rs.1,22,585 crore, representing 20.13% of the hospital sector’s total market value.

11-12 June: Price Consolidation Near Rs.8,496 Amid Mixed Market Signals

In the final two trading sessions of the week, Apollo Hospitals’ stock price stabilised near Rs.8,496, with minor gains of +0.10% on 11 June and +0.01% on 12 June. Trading volumes were lower compared to earlier in the week, reflecting a pause after the strong rally.

The Sensex showed mixed performance, declining on 11 June by 0.53% before rebounding 2.20% on 12 June. Apollo Hospitals outperformed the benchmark on both days, maintaining its relative strength. The stock’s technical indicators continued to signal a bullish trend, supported by its position above all key moving averages.

Derivatives market activity remained elevated, with open interest and call option volumes sustaining high levels, indicating ongoing investor interest and positioning ahead of the month-end expiry.

Key Takeaways

Positive Signals: Apollo Hospitals demonstrated strong price appreciation of 2.32% over the week, significantly outperforming the Sensex’s 0.57% gain. The stock hit multiple 52-week highs, reflecting sustained bullish momentum supported by robust technical indicators and strong fundamentals including a high ROCE of 17.13% and consistent quarterly growth.

Derivatives market activity was a key driver, with surging open interest and call option volumes signalling growing investor confidence and bullish positioning ahead of the June expiry. Institutional ownership remains high at 65.61%, providing stability and endorsement of the company’s prospects.

Cautionary Notes: Despite strong derivatives activity, delivery volumes showed volatility, with a sharp decline early in the week followed by a rebound, indicating some short-term trading preference over long-term holding. Minor technical divergences such as mildly bearish monthly KST and weekly OBV indicators warrant monitoring for potential shifts in momentum.

Broader market conditions remain mixed, with the Sensex trading below key moving averages and exhibiting cautious sentiment. Investors should watch for any sectoral or macroeconomic developments that could impact the hospital sector’s trajectory.

Conclusion

Apollo Hospitals Enterprise Ltd. delivered a commendable performance in the week ending 12 June 2026, marked by multiple new 52-week highs, strong derivatives market participation, and solid fundamental backing. The stock’s 2.32% weekly gain outpaced the Sensex by 1.75 percentage points, underscoring its leadership within the hospital sector and resilience amid mixed market conditions.

Technical indicators and institutional support reinforce the positive outlook, while active call option positioning ahead of expiry highlights market optimism. However, investors should remain attentive to delivery volume trends and broader market signals to gauge the sustainability of this momentum. Overall, Apollo Hospitals remains a key large-cap stock exhibiting robust growth and market-beating qualities in the current environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →